Sphera Funds Management Ltd. Albireo Pharma, Inc. Transaction History

Sphera Funds Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.01 - $23.78 $1.89 Million - $2.49 Million	104,828 Added 29.2%	463,828 $10 Million
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $5.86 Million - $9.47 Million	359,000 New	359,000 $6.95 Million
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $5.48 Million - $7.32 Million	-173,600 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$23.19 - $41.61 $4.03 Million - $7.22 Million	173,600 New	173,600 $5.79 Million
Q1 2018 May 10, 2018	SELL	$26.78 - $39.35 $948,842 - $1.39 Million	-35,431 Closed	0 $0

Q4 2017 Feb 12, 2018	SELL	$21.56 - $28.14 $1.58 Million - $2.06 Million	-73,095 Reduced 67.35%	35,431 $907,000
Q3 2017 Nov 09, 2017	BUY	$20.44 - $25.65 $2.22 Million - $2.78 Million	108,526	108,526 $2.27 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.